Keyhaven Capital Partners backs Duke Street’s acquisition of ForLife and Trio
- ForLife Group is a European medical device developer, manufacturer and distributor for stoma care, previously owned by GHD
- In parallel, the assets of Trio Healthcare were acquired, adding new and innovative product technology to complement ForLife’s existing portfolio
- This transaction marks Keyhaven’s second investment this year
The corporate carve out of ForLife from GHD GesundHeits GmbH (“GHD”), Germany's largest outpatient health, therapy and service company, marks Keyhaven’s second investment in 2024.
The sale includes ForLife’s development and production centre in Berlin, as well as the distributor Oakmed in the UK. Following the divestment, GHD and ForLife will remain close partners and continue to serve ostomy patients in Germany.
Founded in Berlin in 1990, ForLife designs, develops and manufactures high-quality medical devices and aids with a core focus on stoma care. They work closely with patients and healthcare professionals to improve people's health and quality of life with ostomy, as well as continence, nutrition and wound care needs.
To complement the purchase, the transaction simultaneously sees the asset acquisition of Trio Healthcare Ltd (“Trio”), specialists in stoma care based in Yorkshire, England. This includes the Genii™ stoma bags, containing the unique Sil2 Breathable Silicone Technology®, which will now be available to a much broader population of patients.
These combined acquisitions will create a player of growth and scale in the ostomy care market. The investment into ForLife will further strengthen its product development and substantially increase its distribution capabilities, supporting its ability to reach more ostomy patients across European markets.
ENDS
About Keyhaven Capital Partners
Keyhaven is a specialist private equity firm dedicated to the European lower mid-market, focused on co-underwriting transactions with local sponsors. With a diverse team, a network embedded in local markets and a flexible approach to deal making, Keyhaven works with niche industry leaders to accelerate growth, building robust, sustainable businesses that deliver for their investors, employees and local communities.
Since its foundation in 2003, Keyhaven has invested or advised on investments worth in excess of €2.2 billion, representing over 65 transactions across Europe.
About Duke Street
Duke Street have backed growth in mid-market European businesses for over twenty years. The investment strategy is concentrated on four sectors: Consumer, Healthcare, Industrials & Engineering and Services. Typically investing in companies with an enterprise value of between €50m - €350m. The strategy is to identify differentiated opportunities for investors and to transform the long-term prospects of the invested companies.
Duke Street has invested over €3bn in more than 50 companies over the last 25 years.
For all media enquiries, please contact:
Instinctif Partners
Keyhaven@instinctif.com
+44 20 7457 2020